Biora Therapeutics (BIOR) Misses Q3 EPS by 504c

Biora Therapeutics (NASDAQ: BIOR) reported Q3 EPS of ($5.04). Revenue for the quarter came in at $30 thousand.

For earnings history and earnings-related data on Biora Therapeutics (BIOR) click here.

You May Also Be Interested In

• Stifel Reiterates Buy Rating on Palo Alto Networks (PANW)
• Zscaler (ZS) PT Raised to $220 at Jefferies
• Barclays Reinstates GFL Environmental (GFL) at Overweight